REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Adverum Biotechnologies will present at the following upcoming investor conferences:
- Cantor Fitzgerald Global Healthcare Conference 2023 on Thursday, September 28, 2023 at 8:00 a.m. ET.
- Chardan's 7th Annual Genetics Medicines Conference on Monday, October 2, 2023 at 10:00 a.m. ET.
The on-demand webcast corporate presentation ...